Albrecht PIIPER,Christian SCHMITHALS,Thomas J. VOGL
申请号：
US15748895
公开号：
US20180214582A1
申请日:
2016.08.01
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to an imaging diagnostic method, comprising a contrast agent including a contrast enhancer in a magnetic resonance imaging (MRI) assisted diagnosis of carcinoma diseases or carcinomas, in particular of hepatocellular carcinoma (HCC). The contrast agent is preferably a gadolinium compound, preferably Gd-DTPA including iRGD as a contrast enhancer, for the improved imaging of carcinomas, in particular HCC, in MRI. The invention furthermore relates to a method for the risk stratification of patients and subjects using the aforementioned diagnosis.
